Application of Neuroimaging for the Prediction of Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke
© 2022 S. Karger AG, Basel..
BACKGROUND: Ischemic stroke is a common cerebrovascular disease with high morbidity, disability, and mortality worldwide. Currently, recombinant tissue plasminogen activator is the main intravenous thrombolysis agent for the treatment of acute ischemic stroke within 4.5 h after onset. Hemorrhagic transformation (HT) is the most serious complication of intravenous thrombolysis, which can significantly aggravate clinical poor prognosis. Therefore, it is important to early predict the risk of post-thrombolysis HT in patients with acute ischemic stroke.
SUMMARY: Recently, several studies have reported that neuroimaging techniques have potential value in predicting HT after intravenous thrombolysis in patients with acute ischemic stroke. The corresponding neuroimaging parameters may be effective predictors of HT after intravenous thrombolysis. In this review, we summarized and discussed the application of neuroimaging techniques and related parameters in predicting HT after intravenous thrombolysis.
KEY MESSAGES: Recognizing and understanding the predictive performance of neuroimaging parameters for HT may help assess the risk of HT after intravenous thrombolysis in patients with acute ischemic stroke and make an appropriate treatment decision.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Cerebrovascular diseases (Basel, Switzerland) - 52(2023), 1 vom: 01., Seite 1-10 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yang, Miaomiao [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 3.4.21.68 |
---|
Anmerkungen: |
Date Completed 31.01.2023 Date Revised 17.02.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1159/000524749 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341835404 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341835404 | ||
003 | DE-627 | ||
005 | 20231226012705.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1159/000524749 |2 doi | |
028 | 5 | 2 | |a pubmed24n1139.xml |
035 | |a (DE-627)NLM341835404 | ||
035 | |a (NLM)35661647 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yang, Miaomiao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Application of Neuroimaging for the Prediction of Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 31.01.2023 | ||
500 | |a Date Revised 17.02.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 S. Karger AG, Basel. | ||
520 | |a BACKGROUND: Ischemic stroke is a common cerebrovascular disease with high morbidity, disability, and mortality worldwide. Currently, recombinant tissue plasminogen activator is the main intravenous thrombolysis agent for the treatment of acute ischemic stroke within 4.5 h after onset. Hemorrhagic transformation (HT) is the most serious complication of intravenous thrombolysis, which can significantly aggravate clinical poor prognosis. Therefore, it is important to early predict the risk of post-thrombolysis HT in patients with acute ischemic stroke | ||
520 | |a SUMMARY: Recently, several studies have reported that neuroimaging techniques have potential value in predicting HT after intravenous thrombolysis in patients with acute ischemic stroke. The corresponding neuroimaging parameters may be effective predictors of HT after intravenous thrombolysis. In this review, we summarized and discussed the application of neuroimaging techniques and related parameters in predicting HT after intravenous thrombolysis | ||
520 | |a KEY MESSAGES: Recognizing and understanding the predictive performance of neuroimaging parameters for HT may help assess the risk of HT after intravenous thrombolysis in patients with acute ischemic stroke and make an appropriate treatment decision | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Hemorrhagic transformation | |
650 | 4 | |a Intravenous thrombolysis | |
650 | 4 | |a Ischemic stroke | |
650 | 4 | |a Neuroimaging | |
650 | 7 | |a Tissue Plasminogen Activator |2 NLM | |
650 | 7 | |a EC 3.4.21.68 |2 NLM | |
650 | 7 | |a Fibrinolytic Agents |2 NLM | |
700 | 1 | |a Tang, Lisha |e verfasserin |4 aut | |
700 | 1 | |a Hu, Zhiping |e verfasserin |4 aut | |
700 | 1 | |a Tang, Xiangqi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cerebrovascular diseases (Basel, Switzerland) |d 1997 |g 52(2023), 1 vom: 01., Seite 1-10 |w (DE-627)NLM090577663 |x 1421-9786 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2023 |g number:1 |g day:01 |g pages:1-10 |
856 | 4 | 0 | |u http://dx.doi.org/10.1159/000524749 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2023 |e 1 |b 01 |h 1-10 |